Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in IntangiblesChange in IntangiblesChange in ReceivablesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares IssuedShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueEBIATGross ProfitLeasesLong-Term Debt IssuancesLong-Term Debt RepaymentsMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetShares IssuedShares OutstandingShares OutstandingShares Repurchased
Ratios

Healthequity (HQY) Shares Repurchased (2024 - 2026)

Healthequity's quarterly Shares Repurchased came in at $81.0 million in Q1 2026, up 28.64% year-on-year from $63.0 million in Q1 2025, and down 12.34% quarter-over-quarter from $92.4 million in Q4 2025.

Healthequity has reported Shares Repurchased for 3 years, with the latest figure at $81.0 million in Q1 2026.

  • For the quarter ending Q1 2026, Shares Repurchased rose 28.64% year-over-year to $81.0 million; the trailing twelve-month figure through Jan 2026 stood at $299.3 million (up 146.31% YoY), and the FY2026 full-year result was $299.3 million, up 146.31% from the prior year.
  • Shares Repurchased for Q1 2026 stood at $81.0 million, down from $92.4 million in the prior quarter.
  • The five-year high for Shares Repurchased was $92.4 million in Q4 2025, with the low at $58.5 million in Q4 2024.
  • Average Shares Repurchased over 3 years is $70.1 million, with a median of $64.9 million recorded in 2025.
  • Year-over-year, Shares Repurchased soared 57.95% in 2025 and increased 28.64% in 2026.
  • Tracing HQY's Shares Repurchased over 3 years: stood at $58.5 million in 2024, then soared by 57.95% to $92.4 million in 2025, then declined by 12.34% to $81.0 million in 2026.
  • The last three Shares Repurchased figures came in at $81.0 million (Q1 2026), $92.4 million (Q4 2025), and $66.7 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares Repurchased (Qtr)
1 Veeva Systems 30.85 Bn 24.28 Bn 622.47 Mn -
2 BrightSpring Health Services 12.29 Bn 11.41 Bn 482.22 Mn 60.00 Mn
3 Healthequity 7.80 Bn 7.48 Bn 256.31 Mn 123.31 Mn
4 Hinge Health 4.82 Bn 4.51 Bn 154.23 Mn 104.97 Mn
5 Doximity 4.21 Bn 3.46 Bn 125.97 Mn 90.53 Mn
6 Waystar Holding 4.18 Bn 4.03 Bn 268.04 Mn -
7 10x Genomics 3.78 Bn 3.24 Bn 106.18 Mn -
8 Privia Health 2.65 Bn 2.28 Bn 595.71 Mn -
9 Omnicell 1.95 Bn 1.78 Bn 140.36 Mn -
10 Teladoc Health 1.42 Bn 672.39 Mn 562.57 Mn -

Historic Data

Download Data 🔒
DateValue
Apr 30, 2026 123.31 Mn
Apr 30, 2026 123.31 Mn
Jan 31, 2026 81.02 Mn
Jan 31, 2026 81.02 Mn
Oct 31, 2025 92.42 Mn
Oct 31, 2025 92.42 Mn
Jul 31, 2025 66.75 Mn
Jul 31, 2025 66.75 Mn
Apr 30, 2025 59.07 Mn
Apr 30, 2025 59.07 Mn
Jan 31, 2025 62.98 Mn
Jan 31, 2025 62.98 Mn
Oct 31, 2024 58.51 Mn
Oct 31, 2024 58.51 Mn